U.S. flag

An official website of the United States government

NM_000527.4(LDLR):c.-107T>C AND Familial hypercholesterolemia

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 2, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000773304.13

Allele description [Variation Report for NM_000527.4(LDLR):c.-107T>C]

NM_000527.4(LDLR):c.-107T>C

Genes:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
LDLR-AS1:LDLR antisense RNA 1 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.4(LDLR):c.-107T>C
HGVS:
  • NC_000019.10:g.11089442T>C
  • NG_009060.1:g.5062T>C
  • NM_000527.4:c.-107T>C
  • NM_001195798.1:c.-107T>C
  • NM_001195799.1:c.-107T>C
  • NM_001195800.1:c.-107T>C
  • NM_001195803.1:c.-107T>C
  • LRG_274t1:c.-107T>C
  • LRG_274:g.5062T>C
  • NC_000019.9:g.11200118T>C
  • NR_163945.1:n.218A>G
Links:
dbSNP: rs1568582310
NCBI 1000 Genomes Browser:
rs1568582310
Molecular consequence:
  • NR_163945.1:n.218A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000906996Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)		Uncertain significance
(Apr 2, 2019) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Color Diagnostics, LLC DBA Color Health, SCV000906996.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is located in the sterol independent regulatory element (SIRE, PMID: 10671569, 25248394) of the promoter/regulatory region of the LDLR gene. To our knowledge, functional assays have not been performed for this variant to assess the impact on the transcriptional or translational regulation. This variant has not been reported in individuals affected with familial hypercholesterolemia in the literature. This variant position is not covered by the Genome Aggregation Database (gnomAD) and the variant allele frequency in the general population is unknown. Available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024